Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Teng-Teng Chung"'
Autor:
Anneke Graf, Eleni Armeni, Louise Dickinson, Matthew Stubbs, Brian Craven, Umasuthan Srirangalingam, Teng-Teng Chung
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2022)
Rare cases of vaccine-induced Immune thrombocytopenia and thrombosis (VITT) are being identified after vaccination with the SARS-CoV-2 Oxford–AstraZeneca vaccination. We report on two such patients with associated adrenal involvement, which is now
Externí odkaz:
https://doaj.org/article/507b71d476ba4231880d606653294ece
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2021)
We observed a novel therapeutic response with cabergoline in a male patient with a dopamine-secreting head and neck paraganglioma (HNPGL), macroprolactinoma and germline succinate dehydrogenase C mutation (SDHC). The macroprolactinoma was treated wit
Externí odkaz:
https://doaj.org/article/5fb4ba49aacb4266bd524be81da88132
Autor:
Anand Velusamy, Angela F. Brady, Joseph Carlow, Huw Dorkins, Rebecca Igbokwe, Benjamin Whitelaw, Teng-Teng Chung, Rachel Harrison, Fiona Lalloo, Paul Brennan, Louise Izatt, Schaida Schirwani, Alan Kelsall, Barbara McGowan, Sophie T Williams, Rosemarie Davidson, Paul V. Carroll, Nicola Tufton, Patrick J. Morrison, Soo-Mi Park, Christopher Bowles, John Newell-Price, Julian Adlard, Monika Kosicka-Slawinska, Eamonn R. Maher, Richard M. Martin, Lara Hawkes, Rebecca Dyer, Scott Akker, Rupert Obholzer, Florian Wernig, Tricia Tan, Ruth T Casey, Prodromos Chatzikyriakou, Gemma White, Anna L. Mitchell, Mary Porteous
Publikováno v:
Clinical endocrinologyREFERENCES. 96(4)
Objective Phaeochromocytomas and paragangliomas (PPGL) are rare, but strongly heritable tumours. Variants in succinate dehydrogenase (SDH) subunits are identified in approximately 25% of cases. However, clinical and genetic information of patients wi
Autor:
Gerard Ruiz-Babot, Alessandra Mancini, Demetris Mariannis, Teng-Teng Chung, Tarek Ezzat Abdel-Aziz, Leonardo Guasti, Peter J. King, Fausto Palazzo, Irene Hadjidemetriou, Katja Kiseljak-Vassiliades, Margaret E. Wierman, William Drake, Aimee diMarco, Laila Parvanta, James Pittaway, Celso E. Gomez-Sanchez, Katia Mariniello
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 193
The adrenal cortex governs fundamental metabolic processes though synthesis of glucocorticoid, miner-alocorticoids and androgens. Studies in rodents have demonstrated that the cortex undergoes a self-renewal process and that capsular/subcapsular stem
Autor:
Tom R. Kurzawinski, Jamshed Bomanji, Simon Wan, Teng-Teng Chung, Abdulrhman Alnaim, Tarek Ezzat Abdel-Aziz
Publikováno v:
European Journal of Surgical Oncology. 43:2387-2388
Publikováno v:
Clinical Endocrinology. 71:86-91
Summary Aims To evaluate the long-term efficacy and safety of pegvisomant as a treatment for acromegaly. Design Retrospective analysis of clinical and trial data from all patients treated with pegvisomant since 1997 at two centres with common protoco
Publikováno v:
Best Practice & Research Clinical Endocrinology & Metabolism. 23:159-165
Familial glucocorticoid deficiency is an autosomal recessive disorder resulting from defects in the action of adrenocorticotropic hormone (ACTH) to stimulate glucocorticoid synthesis in the adrenal. Production of mineralocorticoids by the adrenal is
Publikováno v:
Clinical endocrinology. 84(4)
BACKGROUND Patients taking hydrocortisone (HC) replacement for primary or secondary adrenal failure require individual adjustment of their dose. In addition to modifying the administered doses of HC for each patient, physicians are increasingly inter
Autor:
John P. Monson, G. M. Besser, Ashley B. Grossman, D. M. Walker, Jane Evanson, W. M. Drake, Scott Akker, Teng-Teng Chung
Publikováno v:
Clinical endocrinology. 68(6)
Summary Background Published data suggest that growth hormone replacement (GHR) may be given safely to patients with hypopituitarism consequent upon a pituitary/peripituitary tumour. However, a preponderance of patients treated with external pituitar
Autor:
Jane Evanson, Teng-Teng Chung, W. M. Drake, G. M. Besser, S. L. Chew, Ashley B. Grossman, D. M. Walker, John P. Monson, Piers N. Plowman
Publikováno v:
Clinical endocrinology. 63(3)
Summary Objective GH replacement is widely used in the management of patients with adult-onset (AO)-GH deficiency (GHD). In most cases, AO-GHD arises as a result of pituitary/peripituitary tumours and/or their treatment, but the effect of GH replacem